Lymphoma in Patients with Rheumatoid Arthritis

Lymphoma in Patients with Rheumatoid Arthritis
复制标题

类风湿关节炎患者的淋巴瘤

DOI:
10.2165/00002018-199920060-00002
复制
发表时间:
1999
期刊:
影响因子:
4.2
通讯作者:
S. Paget
S. Paget
中科院分区:
医学2区
文献类型:
--
作者:
L. Georgescu;S. Paget

文献摘要

参考文献

被引文献

相似文献

在接受甲氨蝶呤治疗的类风湿性关节炎患者中,淋巴瘤的病例继续出现。大多数淋巴增生患者具有免疫抑制相关淋巴瘤的特征。类风湿性关节炎本身和甲氨蝶呤的作用共同导致免疫抑制状态。类风湿性关节炎患者在接受甲氨蝶呤治疗时发生淋巴瘤的可能致癌机制和危险因素包括:(i) 强烈的免疫抑制和严重的疾病与遗传倾向相结合; (ii) 诸如 Epstein-Barr 病毒等促癌病毒潜伏感染的频率增加。甲氨蝶呤在这些淋巴瘤发展中的病因学作用得到了一些类风湿性关节炎患者在停止甲氨蝶呤后这些恶性肿瘤的自发缓解的支持。治疗接受甲氨蝶呤的类风湿性关节炎患者的医生应警惕提示淋巴瘤的体征和症状,尤其是那些患有严重合并症、长期存在且病情严重且更有可能免疫抑制的患者。如果这些患者出现淋巴瘤,应停用甲氨蝶呤。可能会出现自发缓解,如果临床可能,建议观察一段时间。如果几个月后出现功能恶化或出现淋巴增殖性器官侵犯的迹象,则应进行特异性抗肿瘤治疗。
An increasing number of instances of lymphoma in patients with rheumatoid arthritis who are treated with methotrexate continue to appear. The majority of patients with lymphoproliferation have features of immunosuppression-associated lymphoma. Rheumatoid arthritis itself and the actions of methotrexate concur in leading to a immunosuppressed state.Possible oncogenic mechanisms and the risk factors for patients with rheumatoid arthritis to develop lymphoma while receiving methotrexate include: (i) intense immunosuppression and severe disease in combination with genetic predisposition and; (ii) an increased frequency of latent infection with pro-oncogenic viruses like Epstein-Barr virus.The aetiological role of methotrexate in the development of these lymphomas is supported by the spontaneous remission of these malignancies in some of patients with rheumatoid arthritis after methotrexate has been stopped. The physicians caring for patients with rheumatoid arthritis receiving methotrexate should be vigilant about signs and symptoms suggestive of lymphoma, mostly in those patients with significant comorbidity, long standing and severe disease who are more likely to be immunosuppressed. If a lymphoma appears in these patients, methotrexate should be stopped.Spontaneous remission may occur and a period of observation is advisable when clinically possible. If functional deterioration appears or there are signs of lymphoproliferative organ invasion after several months then specific antineoplastic treatment should be instituted.
DOI: 10.1016/0002-9343(85)90312-2
发表时间: 1985
期刊: The American journal of medicine
影响因子: --
作者:
Weinstein,A;Marlowe,S;Korn,J;Farouhar,F
通讯作者: Farouhar,F
类风湿关节炎患者再循环淋巴细胞的特征:胸导管淋巴液中自然杀伤细胞的选择性缺乏。
DOI: --
发表时间: 1984
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Fox,RI;Fong,S;Tsoukas,C;Vaughan,JH
通讯作者: Vaughan,JH
DOI: 10.1002/art.1780270106
发表时间: 1984
影响因子: --
作者:
Carol L. Young;T. C. Adamson;J. Vaughan;Robert I. Fox
通讯作者: Carol L. Young;T. C. Adamson;J. Vaughan;Robert I. Fox
类风湿性关节炎患者淋巴瘤中的 Epstein-Barr 病毒克隆。
DOI: 10.1002/art.1780390415
发表时间: 1996
影响因子: --
作者:
vandeRijn,M;Cleary,ML;Variakojis,D;Warnke,RA;Chang,PP;Kamel,OW
通讯作者: Kamel,OW
类风湿性关节炎中的 Epstein-Barr 病毒。
DOI: --
发表时间: 1985
期刊: Clinics in rheumatic diseases
影响因子: --
作者:
Fox,RI;Lotz,M;Rhodes,G;Vaughan,JH
通讯作者: Vaughan,JH